| 
				
 4. | 
				I
				certify under 18 U.S.C. § 1001 that the cruise ship operator
				has adopted health and safety protocols that meet CDC’s
				standards for mitigating the risk of COVID-19 among passengers
				and crew onboard the cruise ship named in this application, and
				will modify these protocols as needed to protect the public’s
				health as required by CDC technical instructions or orders.
				
 | 
		
			| 
				5.
				
				 | 
				I
				certify under 18 U.S.C. § 1001 that the cruise ship operator
				has sufficient medical and point-of-care laboratory capabilities
				and staff on board the cruise ship to manage severe COVID-19
				cases and outbreaks in exigent circumstances as required by CDC
				technical instructions or orders.
				
 | 
		
			| 
				6.
				
				 | 
				I
				certify under 18 U.S.C. § 1001 that the cruise ship operator
				is in compliance with all other requirements contained in CDC’s
				framework for mitigating the risk of COVID-19 on board cruise
				ships and agree to continue to comply with these requirements.
				
 | 
		
			| 
				7. | 
				I
				have documented the written approval of all U.S. port and local
				health authorities where the cruise ship named in this
				application intends to dock or make port during a restricted
				passenger voyage. Such written approval includes the following:
				(1)
				A medical care agreement between the cruise ship operator and
				health care entities, addressing evacuation to onshore hospitals
				for passengers and crew in need of care, in accordance with CDC
				technical instructions and orders. 
				
				(2)
				A housing agreement between the cruise ship operator and one or
				more shoreside facilities for isolation and quarantine of
				COVID-19 cases and close contacts, respectively, identified from
				the day of embarkation through disembarkation for each voyage, in
				accordance with CDC technical instructions and orders.
				(3)
				A port agreement between the cruise ship operator and port
				authority limiting the number of cruise ships at any single port
				in order to not overburden the public health response resources
				of any single jurisdiction in the event of a COVID-19 outbreak.
				
 | 
		
			| 
				8. | 
				I
				agree, upon request, to make the cruise ship operator’s
				properties and records available for inspection to allow CDC to
				ascertain compliance with its requirements. Such properties and
				records include but are not limited to vessels, facilities,
				vehicles, equipment, communications, manifests, list of
				passengers, and employee and passenger health records. I also
				agree to make any crew member or other personnel involved in the
				operation of a cruise ship available for interview by CDC. 
				
				
 | 
		
			| 
				9. | 
				I
				agree, upon request, to submit proof to CDC of having been
				inspected by any other agency or entity with authority,
				jurisdiction, or oversight over any aspect of the cruise ship
				operator’s operations.
				
 | 
		
			| 
				10. | 
				The
				cruise ship operator has established mechanisms to ensure
				compliance, including reporting mechanisms to notify CDC and USCG
				in writing within 24 hours of the occurrence of any deviations
				from CDC’s requirements, whether intentional, or as a
				result of error or omission, and agree to take corrective steps
				to rectify those deviations.
				
 | 
		
			| 
				11. | 
				The
				cruise ship operator has in marketing materials, on its website,
				and in offerings for voyages, notified prospective passengers
				prior to accepting a reservation of any CDC travel health
				notices, warnings, or recommendations relating to cruise travel
				or any planned ports of call. Such notifications further advise
				prospective passengers that, if COVID-19 has been detected in
				passengers or crew on board the cruise ship during a voyage, the
				voyage will be ended immediately and the ship returned to the
				U.S. port of embarkation, and their subsequent travel, including
				their return home, may be restricted or delayed.
				
 | 
		
			| 
				12. | 
				Prior
				to embarkation, the cruise ship operator will screen passengers
				and crew for signs and symptoms of or known exposure to COVID-19
				and deny boarding to anyone who is suspected of having COVID-19
				or is an identified contact of a confirmed or suspected case, in
				accordance with CDC technical instructions or orders.
				
 | 
		
			| 
				13. | 
				The
				cruise ship operator will conduct laboratory testing of all
				passengers and crew on the day of embarkation and again on the
				day of disembarkation in accordance with CDC technical
				instructions or orders. Laboratory test results will be available
				prior to passengers embarking and prior to passengers and crew
				departing for their final destinations after disembarking the
				ship.
				
 | 
		
			| 
				14. | 
				The
				cruise ship operator will immediately conduct laboratory testing
				of any passengers and crew who report illness consistent with
				COVID-19 during the voyage with rapid point-of-care results as
				required by CDC technical instructions or orders. Identified
				close contacts of cases must also be laboratory tested with rapid
				point-of-care results.
				
 | 
		
			| 
				15. | 
				The
				cruise ship operator will report syndromic surveillance and all
				laboratory test results using CDC’s Enhanced Data
				Collection (EDC) form as required by CDC technical instructions
				or orders. | 
		
			| 
				16. | 
				The
				cruise ship operator has met CDC’s standards for hand
				hygiene, use of face masks, and social distancing for passengers
				and crew, as well as ship sanitation, as required by CDC
				technical instructions or orders. 
				 | 
		
			| 
				17. | 
				The
				cruise ship operator has modified meal service and entertainment
				venues to facilitate social distancing.
				
 | 
		
			| 
				18. | 
				I
				understand and acknowledge that in light of public health
				considerations and based on evidence gained through review and
				evaluation of the cruise ship operators’ practices and
				procedures, including through simulated voyages, CDC may also
				require the following:
					A
					monitored observation period of passengers prior to embarkingPost-disembarkation
					laboratory testing of passengers and crew 
					Additional
					laboratory testing of passengers and crew and reporting of
					results during a voyage 
				
 | 
		
			| 
				19. | 
				I
				understand and acknowledge that CDC may issue additional
				technical instructions or orders regarding health and safety
				standards for restricted passenger voyages.
				
 | 
		
			| 
				20. | 
				I
				understand and acknowledge that CDC may require a cruise ship
				operator to amend or modify its COVID-19 Conditional Sailing
				Certificate after one has been issued based on public health
				considerations specific to the cruise ship, cruise ship operator,
				or affecting the health or safety of cruise travel as a whole.
				
 | 
		
			| 
				21. | 
				I
				understand and acknowledge that CDC may deny an application for a
				COVID-19 Conditional Sailing Certificate, or revoke or suspend a
				COVID-19 Conditional Sailing Certificate after one has been
				issued if:
					the
					cruise ship operator is not in compliance with CDC’s
					standards for mitigating the risk of COVID-19 on board cruise
					ships; orthe
					cruise ship operator is not in compliance with the terms of its
					COVID-19 Conditional Sailing Certificate; ornecessary
					to protect human health or safety based on public health
					considerations specific to the particular cruise ship operator,
					cruise ship, or affecting cruise travel as a whole. 
				
 | 
		
			| 
				
 I
				understand and acknowledge that I am submitting this form as part
				of an application to obtain permission to commence cruise ship
				passenger operations in U.S. waters and that the statements
				contained herein are true and correct to the best of my knowledge
				and belief. 
				 
 I
				acknowledge that any false or misleading statements or omissions
				may endanger health and safety, including but not limited to the
				loss of lives and other irreparable harm. Therefore, false or
				misleading statements or omissions may result in criminal and
				civil actions for fines, penalties, damages, and imprisonment.  
				
 | 
		
			| 
				Chief
				Executive Officer (or Equivalent) of Operating Company | 
		
			| 
				Last
				name: | 
				First
				name: | 
				Middle
				initial: | 
		
			| 
				Signature: | 
				Date: | 
		
			| 
				Chief
				Compliance Officer (or Equivalent) of Operating Company | 
		
			| 
				Last
				name: | 
				First
				name: | 
				Middle
				initial: | 
		
			| 
				Signature: | 
				Date: | 
		
			| 
				Highest-Ranking
				Medical Officer of Operating Company | 
		
			| 
				Last
				name: | 
				First
				name: | 
				Middle
				initial: | 
		
			| 
				Signature: | 
				Date: | 
		
			| 
				Chief
				Executive Officer (or Equivalent) of Parent Company | 
		
			| 
				Last
				name: 
 | 
				First
				name: | 
				Middle
				initial: | 
		
			| 
				Signature: 
 | 
				Date: | 
		
			| 
				Chief
				Compliance Officer (or Equivalent) of Parent Company | 
		
			| 
				Last
				name: 
 | 
				First
				name: | 
				Middle
				initial: | 
		
			| 
				Signature: 
 | 
				Date: | 
		
			| 
				Highest-Ranking
				Medical Officer of Parent Company | 
		
			| 
				Last
				name: 
 | 
				First
				name: | 
				Middle
				initial: | 
		
			| 
				Signature: 
 | 
				Date: | 
		
			| 
				For
				official use only: 
 
 
 
 
 
 
 | 
				
 |